Praxis Precision Medicines has won Food and Drug Administration breakthrough-therapy designation for its ulixacaltamide drug candidate for the treatment of patients with essential tremor.

Q: I am 46 years old and first noticed a few tremors when I was in my mid-20s. My grandmother, mother and one of my aunts experienced head tremors. The tremors are somewhat worse now but not enough to ...

As we age, performing daily tasks and the activities we enjoy can become more difficult. Some seniors may begin experiencing movement disorders that further inhibit their physical abilities and the ...

The Breakthrough Therapy Designation was granted based on the positive topline results from the Essential3 Phase 3 program in essential ...

Praxis Precision Medicines wants to help meet the large unmet need for effective treatment options. Praxis specializes in ...

Praxis Precision Medicines Inc (NASDAQ: PRAX) stock rose after FDA granted BTD for ulixacaltamide to treat essential tremor.

A groundbreaking treatment for Parkinson’s disease and essential tremor is now available in Kentucky and the Norton ...

For those living with essential tremor or tremor-dominant Parkinson’s disease who have not responded to medication, there is hope. Delray Medical Center is now the first hospital in the region to ...

BINGHAMTON, N.Y.--(BUSINESS WIRE)--United Health Services (UHS), one of Upstate New York’s largest and most comprehensive integrated healthcare systems, today announced the launch of its focused ...

Dear Dr. Douma: A few years ago, you described an ailment that produces quivers and shaking of the extremities. I now have the tremors in my right arm and have considerable difficulty writing. My ...

GRAND RAPIDS, MI — Corewell Health in Grand Rapids has implemented a groundbreaking medical procedure for treating essential tremor and tremor-dominant Parkinson’s disease. The non-invasive treatment ...